ConductScience.org, home

Paper35629327

Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.

Kumar GS and 4 others. Life (Basel), 2022. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy. Papers, record 35629327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35629327

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy.
PubMed
Journal
Life (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2024-08-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar GSGeethu Shttps://orcid.org/0000-0002-3636-7918
2Moustafa MMahmoud
3Sahoo AKAmaresh Kumar
4Malý PPetrhttps://orcid.org/0000-0001-8118-0581
5Bharadwaj SShivhttps://orcid.org/0000-0003-2832-8617

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132457487Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.Cancer Gene Ther2021https://conductscience.org/library/papers/32457487PubMed
233946261Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization.Int J Mol Sci2021https://conductscience.org/library/papers/33946261PubMed
332692162Challenges and Opportunities in Cancer Drug Resistance.Chem Rev2021https://conductscience.org/library/papers/32692162PubMed
432162523Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.J Nat Prod2020https://conductscience.org/library/papers/32162523PubMed
526599107Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.PLoS One2015https://conductscience.org/library/papers/26599107PubMed
631925406Dissecting the mechanisms of immune checkpoint therapy.Nat Rev Immunol2020https://conductscience.org/library/papers/31925406PubMed
732998374Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1.Biomolecules2020https://conductscience.org/library/papers/32998374PubMed
834256042Advance investigation on synthetic small-molecule inhibitors targeting PD-1/PD-L1 signaling pathway.Life Sci2021https://conductscience.org/library/papers/34256042PubMed
927094104From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway.Drug Discov Today2016https://conductscience.org/library/papers/27094104PubMed
1021591817Comparison of virtual high-throughput screening methods for the identification of phosphodiesterase-5 inhibitors.J Chem Inf Model2011https://conductscience.org/library/papers/21591817PubMed
1132266087PD-1/PD-L1 pathway: current researches in cancer.Am J Cancer Res2020https://conductscience.org/library/papers/32266087PubMed
1229567705Cancer immunotherapy using checkpoint blockade.Science2018https://conductscience.org/library/papers/29567705PubMed
1315481986A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition.J Med Chem2004https://conductscience.org/library/papers/15481986PubMed
1430563830A Mechanism of Resistance to Antibody-Targeted Immune Attack.Cancer Immunol Res2019https://conductscience.org/library/papers/30563830PubMed
1525491730The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.Expert Opin Ther Targets2015https://conductscience.org/library/papers/25491730PubMed
1628937668Complete protein-protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling.Nat Chem2017https://conductscience.org/library/papers/28937668PubMed
1734209829Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells.Cells2021https://conductscience.org/library/papers/34209829PubMed
1823579614Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.J Comput Aided Mol Des2013https://conductscience.org/library/papers/23579614PubMed
1928189183Radiotherapy for Cancer: Present and Future.Adv Drug Deliv Rev2017https://conductscience.org/library/papers/28189183PubMed
2035408504Molecular Dynamics Simulations: Advances and Applications.Molecules2022https://conductscience.org/library/papers/35408504PubMed

See all 68 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41028248Citronellol silver nanoconjugates as a therapeutic strategy for glioblastoma through computational and experimental evaluation.Sci Rep2025https://conductscience.org/library/papers/41028248PubMed
40504869Linalool-based silver nanoconjugates as potential therapeutics for glioblastoma: in silico and in vitro insights.PLoS One2025https://conductscience.org/library/papers/40504869PubMed
39867321Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition.RSC Adv2025https://conductscience.org/library/papers/39867321PubMed
39779554Targeting PD-1 in Squamous Cell Carcinoma: Flavonoid-based Therapeutics Unveiled through in silico and in vitro Approaches.Curr Comput Aided Drug Des2026https://conductscience.org/library/papers/39779554PubMed
39564188Unlocking Benzosampangine's Potential: A Computational Approach to Investigating, Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking, Dynamic Simulation, and ADMET Profiling.Bioinform Biol Insights2024https://conductscience.org/library/papers/39564188PubMed
39230480Innovative virtual screening of PD-L1 inhibitors: the synergy of molecular similarity, neural networks and GNINA docking.Future Med Chem2024https://conductscience.org/library/papers/39230480PubMed
38808724Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction.Curr Comput Aided Drug Des2025https://conductscience.org/library/papers/38808724PubMed
36982981Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors.Int J Mol Sci2023https://conductscience.org/library/papers/36982981PubMed
36938364A Potential Off-Target Effect of the Wnt/β-Catenin Inhibitor KYA1797K: PD-L1 Binding and Checkpoint Inhibition.Biomed Hub2023https://conductscience.org/library/papers/36938364PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
PDCD1LG280380PubTator's text mininghttps://conductscience.org/library/genes/80380NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35629327

GET https://conductscience.org/api/papers/v1/35629327/references?page=2